TrumpRx Direct-to-Consumer Drug Platform Delayed Amid Senatorial Scrutiny

The planned launch of TrumpRx, an online service intended to facilitate direct prescription drug purchases from manufacturers, has been postponed. This delay follows significant inquiries from Democratic senators regarding the platform's operational legality and oversight mechanisms. Legislators are specifically concerned about potential conflicts of interest related to direct-to-consumer models.